Related Experiment Video

Updated: Mar 11, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:20

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

654

Therapeutic approaches to pediatric pseudotumor cerebri: New insights from literature data

Giovanna Vitaliti1, Piero Pavone1, Nassim Matin2

  • 11 General and Emergency Paediatrics Operative Unit, Policlinico-Vittorio Emanuele University Hospital, University of Catania, Catania, Italy.

International Journal of Immunopathology and Pharmacology
|December 2, 2016
PubMed

Insights

Pseudotumor cerebri syndrome (PTCS), or idiopathic intracranial hypertension (IIH), presents unique challenges in children. This review examines current literature on PTCS treatment strategies specifically for pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Ophthalmology
  • Neuroscience

Background:

  • Pseudotumor cerebri syndrome (PTCS), also known as idiopathic intracranial hypertension (IIH), involves increased intracranial pressure without a mass lesion.
  • While commonly affecting overweight women, PTCS also occurs in men and children, often with atypical presentations.
  • Pediatric PTCS may differ in symptoms and prognosis from adult cases.

Purpose of the Study:

  • To review existing literature on the treatment of pseudotumor cerebri syndrome (PTCS) in children.
  • To consolidate current understanding of PTCS management in pediatric populations.
  • To highlight the need for evidence-based treatment guidelines in pediatric IIH.

Main Methods:

  • Literature review of studies on PTCS treatment in children.
  • Analysis of retrospective data on pediatric idiopathic intracranial hypertension management.
  • Synthesis of available evidence for treatment strategies in pediatric PTCS.

Main Results:

  • Current pediatric PTCS treatment is based on retrospective studies.
  • No prospective or randomized controlled trials specifically evaluate PTCS treatments in children.
  • Treatment approaches for children are extrapolated from adult data.

Conclusions:

  • There is a significant lack of high-quality evidence for PTCS treatment in children.
  • Existing treatment strategies for pediatric PTCS require further investigation through rigorous studies.
  • Development of evidence-based guidelines for pediatric IIH management is crucial.

Keywords:
pediatricspseudotumor cerebritreatment strategies

More Related Videos

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model08:18

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Published on: February 8, 2022

3.0K
A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury06:18

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury

Published on: March 26, 2019

9.7K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.1K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
612